The Global Tissue Nanotransfection Market size is expected to be worth around US$ 15.7 Billion by 2035 from US$ 3.4 Billion in 2025, growing at a CAGR of 16.5% during the forecast period 2026-2035. In 2025, North America led the market, achieving over 42.2% share with a revenue of US$ 1.4 Billion. Growing demand for minimally invasive regenerative therapies is creating strong momentum for the Tissue Nanotransfection Market. North America remains the leading regional market, supported by robust healthcare infrastructure.